Alzheimer's Disease
Conditions
Brief summary
Objective of study is to assess the costs of care, objective and subjective caregiver burden and quality of life in relation to disease severity measured by cognitive function, ADL capabilities and presence of behavioral disturbances in Alzheimer's disease
Interventions
None listed
Sponsors
i3 Innovus
AstraZeneca
Study design
Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Clinical diagnosis of possible or probable Alzheimer's disease, with or without vascular elements * The primary caregiver can be identified * The patient and his/her primary caregiver are both willing and able to participate in the study
Exclusion criteria
* Patient or caregiver affected by alcohol or narcotics to the extent that it interferes with the completion of the study * Patient or caregiver does not understand English * Patient and/ or caregiver is the physician or physician's staff * Patient and/ or caregiver is a family member of the physician or physician's staff
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mini-Mental State Examination (MMSE), Disability Assessment for Dementia Scale (DAD), Neuropsychiatric Inventory Questionnaire (NPI-Q) | Collected one time only |
Secondary
| Measure | Time frame |
|---|---|
| Resource Utilization in Dementia (RUD) | collected one time only |
| Short Form - 12 domains instrument (SF-12) | collected one time only |
| World Health Organization Quality of Life instrument (WHO-QoL) | collected one time only |
| Zarit Caregiver Burden Interview (ZBI) | collected one time only |
| 15 domains Quality of Life Index instrument (15D) | collected one time only |
Countries
Spain, Sweden, United Kingdom, United States
Outcome results
None listed